Published on December 21, 2012 at 5:45 AM
"Multidrug-resistant [tuberculosis (TB)] is at epidemic proportions in some parts of the world -- a growing problem the U.S. is surprisingly unprepared for," the Wall Street Journal reports. Noting "[t]he U.S. beat back multidrug-resistant tuberculosis [MDR-TB] in the 1990s," the newspaper continues, "Today, however, a new threat is emerging as drug resistance worsens abroad and far more dangerous strains develop and spread, including some that are all but untreatable with standard drugs." The Wall Street Journal examines reasons behind a resurgence of MDR-TB in the U.S., treatment and control efforts, and how "funding and expertise are in decline" (12/19).
This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.